ATE361744T1 - Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten - Google Patents
Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheitenInfo
- Publication number
- ATE361744T1 ATE361744T1 AT01900955T AT01900955T ATE361744T1 AT E361744 T1 ATE361744 T1 AT E361744T1 AT 01900955 T AT01900955 T AT 01900955T AT 01900955 T AT01900955 T AT 01900955T AT E361744 T1 ATE361744 T1 AT E361744T1
- Authority
- AT
- Austria
- Prior art keywords
- viral
- diseases
- pharmaceutical composition
- fungal infections
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/32—Tin compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17531300P | 2000-01-10 | 2000-01-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE361744T1 true ATE361744T1 (de) | 2007-06-15 |
Family
ID=22639801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01900955T ATE361744T1 (de) | 2000-01-10 | 2001-01-09 | Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten |
Country Status (7)
Country | Link |
---|---|
US (2) | US6420421B1 (de) |
EP (1) | EP1408941B1 (de) |
AT (1) | ATE361744T1 (de) |
AU (1) | AU2001226361A1 (de) |
CA (1) | CA2396368A1 (de) |
DE (1) | DE60128407T2 (de) |
WO (1) | WO2001051603A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ515140A (en) * | 1999-04-30 | 2003-07-25 | Slil Biomedical Corp | Conformationally restricted polyamine analogs as disease therapies for cancer, epilepsy, alzheimers, infections, grafts and others |
AU4678300A (en) * | 1999-04-30 | 2000-11-17 | Slil Biomedical Corporation | Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases |
WO2002091989A2 (en) * | 2000-11-08 | 2002-11-21 | Slil Biomedical Corporation | Antiviral therapies using polyamine or polyamine analog-amino acid conjugates |
WO2003033455A1 (en) * | 2001-10-16 | 2003-04-24 | Slil Biomedical Corporation | Oligoamine compounds and derivatives thereof for cancer therapy |
FR2890565A1 (fr) * | 2005-09-12 | 2007-03-16 | Laurent Roger Thierry Clerc | Procedes et composition d'une formulation inedite pour le traitement de maladies infectieuses chez l'homme ou l'animal |
US20110045103A1 (en) * | 2009-08-19 | 2011-02-24 | Abukurah Abdul R | Methods for treating aids |
US10478407B2 (en) | 2018-02-23 | 2019-11-19 | The Administrators Of The Tulane Educational Fund | Pharmaceutical composition for viral infections |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3594468A (en) | 1969-04-01 | 1971-07-20 | Vincent R Saurino | Germicidal compositions |
US4021537A (en) | 1973-08-09 | 1977-05-03 | Research Lab Products, Inc. | Oral bactericidal compositions |
US4343815A (en) | 1973-08-30 | 1982-08-10 | M&T Chemicals Inc. | Method for combating fungi and mites using certain triorganotin compounds |
GB1476862A (en) * | 1974-11-13 | 1977-06-16 | Rossmore H | Antimicrobial compositions and methods |
US4204954A (en) | 1978-08-01 | 1980-05-27 | Chemed Corporation | Detoxification of residual quaternaries |
US4321277A (en) | 1978-12-04 | 1982-03-23 | Research Lab Products, Inc. | Germicidal use of compositions containing certain quaternary ammonium compounds |
US4263278A (en) | 1979-07-10 | 1981-04-21 | Saurino Vincent R | Mortuary composition |
US4283421A (en) * | 1979-12-19 | 1981-08-11 | Ray Frank F | Anti-viral treatment |
US4464398A (en) | 1981-08-11 | 1984-08-07 | Huntington Laboratories, Inc. | Germicide and an improved method for killing bacteria, fungus and/or viruses |
US4902720A (en) | 1983-01-10 | 1990-02-20 | Baldone Joseph A | Treatment of virus infections with quaternary ammonium compounds |
US4797420A (en) | 1984-08-14 | 1989-01-10 | Jabco Manufacturing, Inc. | Disinfectant formulation and method of use |
DE3516695A1 (de) | 1985-05-09 | 1986-11-13 | Schering AG, 1000 Berlin und 4709 Bergkamen | Biozide tributylzinnverbindungen |
DK156159C (da) | 1986-04-10 | 1989-11-27 | Gori As | Fremgangsmaade til stabilisering af tributyltin-fungicider til traebeskyttelse |
US4732911A (en) | 1987-03-13 | 1988-03-22 | Betz Laboratories, Inc. | Biocidal compositions and use thereof containing a synergistic mixture of 2-bromo-2-nitropropane-1,3-diol and bis (tri n-butyl tin) oxide |
US4928629A (en) | 1988-06-13 | 1990-05-29 | Iowa State University Research Foundation, Inc. | Egg inoculation method |
US4914132A (en) | 1989-05-25 | 1990-04-03 | Betz Laboratories, Inc. | Biocidal compositions and use thereof containing a synergistic mixute of 2-(decylthio)ethanamine hydrochloride and n-alkyl dimethyl benzyl ammonium chloride |
US4998984A (en) | 1989-11-15 | 1991-03-12 | Mcclendon Evelyn | Premoistened prepackaged disposable disinfectant wiper |
AU3882093A (en) * | 1992-03-23 | 1993-10-21 | Geda International S.A. | Use of antiviral coating for latex items such as condoms |
US5169536A (en) | 1992-04-28 | 1992-12-08 | Betz Laboratories, Inc. | Detoxification agents for surfactant based biocides |
US5336305A (en) | 1993-07-06 | 1994-08-09 | International Laboratory Technology Corp. | Flexible material having barrier properties |
US5417968A (en) | 1993-08-16 | 1995-05-23 | International Laboratory Technology Corp. | Antimicrobial barrier composition |
US5444094A (en) | 1993-08-24 | 1995-08-22 | Stepan Company | Methods and compositions for disinfecting surfaces containing tuberculosis causing bacteria |
US5611938A (en) | 1995-02-28 | 1997-03-18 | Ashland Inc. | Biocidal blends of quaternary ammonium compounds and chlorine dioxide |
US5698207A (en) | 1995-07-26 | 1997-12-16 | International Laboratory Technology Corp. | Burn treatment composition |
-
2001
- 2001-01-09 AU AU2001226361A patent/AU2001226361A1/en not_active Abandoned
- 2001-01-09 WO PCT/US2001/000605 patent/WO2001051603A2/en active IP Right Grant
- 2001-01-09 US US09/757,339 patent/US6420421B1/en not_active Expired - Fee Related
- 2001-01-09 CA CA002396368A patent/CA2396368A1/en not_active Abandoned
- 2001-01-09 DE DE60128407T patent/DE60128407T2/de not_active Expired - Lifetime
- 2001-01-09 EP EP01900955A patent/EP1408941B1/de not_active Expired - Lifetime
- 2001-01-09 AT AT01900955T patent/ATE361744T1/de not_active IP Right Cessation
- 2001-10-23 US US09/999,545 patent/US6462079B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20020061926A1 (en) | 2002-05-23 |
EP1408941A2 (de) | 2004-04-21 |
WO2001051603A2 (en) | 2001-07-19 |
US6420421B1 (en) | 2002-07-16 |
DE60128407T2 (de) | 2008-01-10 |
EP1408941A4 (de) | 2006-01-25 |
US6462079B2 (en) | 2002-10-08 |
AU2001226361A1 (en) | 2001-07-24 |
CA2396368A1 (en) | 2001-07-19 |
DE60128407D1 (de) | 2007-06-21 |
EP1408941B1 (de) | 2007-05-09 |
WO2001051603A3 (en) | 2001-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE185066T1 (de) | Lösung zur verwendung gegen den pilzbefall von nägeln | |
ATE342728T1 (de) | Zubereitung zur behandlung von einer neurologischen erkrankung | |
DE69925256D1 (de) | Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen | |
ATE487493T1 (de) | Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen | |
DE69821667D1 (de) | Kardioverter zur Behandlung von Vorhofflattern | |
DE69823344D1 (de) | Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen | |
DE60233265D1 (de) | 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten | |
DE69422450D1 (de) | Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose | |
ATE163645T1 (de) | Eintopfverfahren zur herstellung von 3- chinoloncarbonsäurederivaten | |
DE60136826D1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
ATE336997T1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
FI935777A (fi) | AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit | |
DE69835536D1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
EE200300504A (et) | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis | |
ATE361744T1 (de) | Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
TR200101841T2 (tr) | Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları | |
DE69307674D1 (de) | HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS | |
ATE294584T1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
EE200300495A (et) | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis | |
EE200300506A (et) | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis | |
DE69906701D1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
ATE145828T1 (de) | Verfahren zur desinfektion von muskelskelettgeweben und so aufbereitete gewebe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1408941 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |